On-Demand Pharma

ASPR's IBx Portfolio

Product: Active Pharma. Ingredients (APIs)

Description of Project: On Demand Pharmaceuticals (ODP) was contracted to develop a domestic production capability for critical active pharmaceutical ingredients (APIs) and final formulated medicines using their proprietary Pharmacy on Demand technology.

Unique Impact: Critical APIs and their starting materials have long been sourced from overseas, and the collaboration with ODP is expected to increase the onshore production of three critical APIs that ultimately form the building blocks for final formulated medicines used to treat critically ill U.S. service members and COVID-19 patients.

Base Award Amount: $20,000,000.00

Category: Vaccine Supplies and Materials, Therapeutics Supplies and Raw Materials